Education only, not medical advice◆21+◆Every dose is an example to finalize with a licensed provider
HormonalFDA-approved medicinePrescription drug
Oxytocin
Pitocin · Syntocinon
Evidence: Approved label. Example dose: finalize with a provider. Not a fact-check stamp.
10-40 IUSubQ1x daily
10-20 IUNasalAs needed
Oxytocin is a naturally occurring nine-amino-acid neuropeptide hormone produced in the hypothalamus and released by the posterior pituitary gland. Often called the 'love hormone' or 'bonding hormone,' it plays critical roles in social bonding, sexual reproduction, childbirth, and lactation. Synthetic oxytocin (Pitocin) has been FDA-approved since the 1980s for induction of labor and control of postpartum hemorrhage.
Quick Start
Route
Subcutaneous (SubQ)
Start low
10-40 IU SubQ
Frequency
1x daily
Timing
No specific requirement
Intranasal: 15-30 minutes before desired effect. SubQ: Per protocol. Pin alone.
❋
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Tiered Protocols · lowest first
Conservative start
10-40 IU · Subcutaneous (SubQ) · 1x daily
conservative starter
10-40 IU
1x daily
Standard
Social & Libido Enhancement
10-20 IU · Nasal · As needed
human study · MacDonald et al. 2011 (Psychoneuroendocrinology)
Intranasal spray is preferred due to blood-brain barrier permeability compared to SubQ injections.
10-20 IU
As needed
Reconstitution CalculatorU-100
050100u
Draw to
— units
◆
◆
◆
01
How it works
Binds to oxytocin receptors (OTR) in the brain, particularly in the amygdala, reducing fear and anxiety responses while enhancing social cognition, trust, and empathy.
Acts on uterine smooth muscle oxytocin receptors to stimulate contractions during labor, and on myoepithelial cells in the breast to promote milk ejection (let-down reflex).
Modulates the hypothalamic-pituitary-adrenal (HPA) axis, reducing cortisol release and attenuating the physiological stress response.
02
What to expect
Early
Days 1–7
Minutes to hours: Acute effects on mood, social openness, and calmness, particularly with intranasal route.
03
Evidence
HumanStrong
AnimalPresent
In-vitroPresent
Each reference below was re-fetched from its PubMed record, and the quoted sentence was
confirmed to appear in that abstract and to support the claim it sits under. Follow any of
them to read the source.
Furthermore, oxytocin increases empathy and seems to exert differential effects on in-group versus out-group preferences.
Furthermore, oxytocin increases empathy and seems to exert differential effects on in-group versus out-group preferences.
Evidence scope. Narrative review of social cognition; no support for the card's subcutaneous regimen.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the
same as saying they are false — it marks where the evidence is missing.
Dose/route: 10-40 IU via Subcutaneous (SubQ), 1x daily. No checked live PubMed abstract supported this complete molecule/formulation/route/dose/frequency combination.
Primary safety claim: Nasal irritation or congestion (intranasal route). No checked live abstract directly established this as the primary concern for the card's exact formulation and regimen.
04
Interactions & stacking
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Documented together
BPC-157Tissue repair peptide and oxytocin act through completely independent mechanisms
MelatoninSleep hormone and social bonding peptide have non-overlapping effects
Thymosin Alpha-1Immune modulation and oxytocin social/anxiolytic effects do not interact
KPVAnti-inflammatory peptide and oxytocin have no known interaction
Keep separate
GHK-CuCopper-peptide may oxidize cysteine disulfide bond critical to oxytocin structure - do not mix in same syringe
GlutathioneReducing agent may disrupt oxytocin disulfide bond required for biological activity - administer separately
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
05
Pharmacokinetics
Illustrative plasma concentration · 0.6 h
Half-life
~3-5 min
IV, 20-30 min intranasal effective duration, longer SubQ
Peak · Tmax
~15-30 min
Intranasal, ~30-60 min SubQ, immediate IV
Elimination
~15-25 min
IV, ~1-2 hours SubQ/intranasal
Bioavailability
~100%
IV. SubQ well-absorbed. Intranasal variable (~2-5% reaches CNS, debated).
Hepatic and renal (oxytocinase/leucyl-cystinyl aminopeptidase in liver and kidneys)
Storage. Store refrigerated at 2-8C. Protect from light. Oxytocin is sensitive to heat and degradation.
06
Regulatory status
FDA-approved as Pitocin for labor induction and postpartum hemorrhage. Intranasal and SubQ use for behavioral/anxiolytic purposes is off-label. Available by prescription.
Put it to work
Calculate, log & track
Open Oxytocin straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.